Q32 Bio (QTTB) Net Cash Flow (2017 - 2026)

Q32 Bio's Net Cash Flow history runs 10 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 119.66% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at -$14.7 million (up 70.55% YoY), while the FY2025 annual figure was -$29.7 million, down 162.66% from the prior year.
• Net Cash Flow was $2.5 million for Q1 2026 at Q32 Bio, up from -$742000.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $138.1 million in Q1 2022 to a low of -$133.0 million in Q3 2022.
• Historically, Net Cash Flow has averaged -$4.4 million across 5 years, with a median of -$10.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow plunged 707.0% in 2022, then surged 779.9% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$9.2 million in 2022, then dropped by 15.94% to -$10.6 million in 2023, then fell by 4.46% to -$11.1 million in 2024, then soared by 93.32% to -$742000.0 in 2025, then jumped by 430.73% to $2.5 million in 2026.
• The last three Net Cash Flow figures came in at $2.5 million (Q1 2026), -$742000.0 (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.